Jerusalem’s Shaare Zedek Medical Centre has become the city’s first and only academic hospital to receive international accreditation by the Joint Commission International (JCI). Independent surveyors from the JCI described Shaare Zedek’s medical activities as “outstanding” and far beyond what the reviewers have observed in many hospitals around the world.

Specific praise was offered to the hospital’s attention to the emotional needs of the patient, and areas pertaining to patient rights.  The surveyors also spoke extremely highly of the cleaning standards of the facilities and singled out the performance of the maintenance, cleaning, and food preparation crews.  Reviews of the surgical complex produced reports describing the operating theatres as among the finest in the world; with similar comments being afforded to the NICU, laboratory, research and many treatment areas.

In an emotional ceremony regularly interrupted by applause, a final report was presented to the hospital staff following a five-day review process in which the hospital was tested on over 1,200 different parameters.  Using words such as “Amazing,” “Phenomenal” and “Incredible”, the surveyors said that Shaare Zedek should take a great deal of pride from their accomplishments.

Shaare Zedek Director General Professor Jonathan Halevy welcomed the announcement saying it provided SZ independent recognition as a hospital operating at the height of international standards.

“This accreditation and the extremely high marks and praise we received through this process provide independent validation for what we and the people of Jerusalem have long known; that Shaare Zedek represents a gold standard of care combining compassion with advanced medicine,” he said.  “I remain confident that what sets our hospital apart is not only the care we provide every day but the fact that we are able to present the best and most qualified team of medical experts and support staff for the needs of our patients.”

The Shaare Zedek Accreditation Team together with the JCI surveyors (from r. to l.) Sarah Goldberg, Tom Murray, Dr. Roy Smoot, Prof. Jonathan Halevy, Dr Ofer Merin, Terry Sharp, Ann Watkins & Hila Shtinboim.

The JCI review is well-regarded as one of the most thorough and important independent reviews in modern healthcare and has become an almost necessary stamp of approval that hospitals are promoting high levels of safety and operations.  Over 800 hospitals in more than 100 nations have undergone the review. While many Israeli hospitals have been reviewed, Shaare Zedek is the only major academic hospital in the Jerusalem area that has successfully undergone the process.

The review saw over two years of preparation involving every aspect of the hospital- both medical and administrative.  The process was overseen by Shaare Zedek Deputy Director General Dr. Ofer Merin, who led a dedicated Accreditation Department directed by Deputy Head Nurse Sarah Goldberg and Hila Shtinboim, all of whom were praised for their efforts in preparing the hospital for the final evaluation. In their report, the surveyors specifically highlighted the unique dedication of the staff and Professor Halevy’s leadership, observing that they are well aware of the challenges involved in leading an institution of this size and complexity.

Hear more about our hospital and activities here in the UK

* indicates required

Shaare Zedek UK will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at katie@shaarezedek.org.uk. We will treat your information with respect. For more information about our privacy practices please click here. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.